About us

The Mission

To become the gold-standard of brain assessment worldwide.

Every brain is unique and requires a customized approach for treatment. Using brain biomarkers, VoxNeuro’s Cognitive Health Assessments™ unlock the full potential of brain recovery and performance.

The Team

Powered by diverse expertise in Neuroscience, Biomedical Engineering, Machine Learning & Artificial Intelligence, Medtech, Regulatory Strategy, Business Development, Occupational Therapy, & Kinesiology; the VoxNeuro team is driven each day to deliver the best-in-class Cognitive Health Assessment™ to the world.

Dr. John F. Connolly
Dr. John F. Connolly
Chief Science Officer, Co-founder

Dr. Connolly is the co-founder and Chief Science Officer of VoxNeuro. Dr. Connolly provides scientific oversight of VoxNeuro’s technology’s applications in acquired brain injuries, neurological disorders and conditions. He also leads the design of projects to investigate new applications for VoxNeuro’s technology. Dr. Connolly envisions and enables innovative methodologies and technological advances for implementation, such as in unanticipated neuropathological illnesses including COVID-19.

Dr. John Connolly received his PhD from King’s College London and is currently a Professor and Senator William McMaster Chair in Cognitive Neuroscience at McMaster University, Ontario. Dr. Connolly is also the Director of the ARiEAL Research Centre at McMaster and is appointed in the Faculties of Engineering, Science and Humanities. His work has been documented in over 300 peer-reviewed publications and has been supported by funding agencies across the world for almost 40 years. He actively reviews research for a wide range of journals and funding agencies, is a Faculty Affiliate at the Vector Institute of Artificial Intelligence, and is a member of Brain Injury Canada’s Scientific Advisory Committee.

James Connolly
James Connolly
Chief Executive Officer, Co-founder

James is the co-founder and CEO of VoxNeuro. James leads VoxNeuro’s overarching strategy and ensures operations remain focused and accelerated. Whether it be employees, clients, partners, investors, or patients, James dedicates his time to serving VoxNeuro’s stakeholders and building out VoxNeuro’s ability to grow its presence and support the communities VoxNeuro serves.

Before co-founding VoxNeuro in 2017 James spent the first nine years of his career in commercial development roles across various industries including automotive, financial, media, and healthcare. Most recently James led US client development for Dentsu Aegis Network, the 3rd largest media conglomerate in the world. Leading their US client team, James led strategic initiatives to drive growth for their largest US accounts including Pfizer, Microsoft, Diageo, and Northrop Grumman. James completed his studies with a speciality in business process integration from the Hogeschool van Amsterdam and a B.Comm. from the University of Ottawa’s Telfer School of Management in 2010.

Kimberly Elliott
Kimberly Elliott
Chief Operating Officer, Co-founder

Kimberly is a co-founder and Chief Operating Officer of VoxNeuro. Kimberly works directly with the CEO and Board of Directors to develop and manage VoxNeuro’s strategic and operational plans, executing on VoxNeuro’s goals for performance and growth. Kimberly oversees business operations as a whole with focus on Legal, Finance, Communications, Clinical Operations, and Human Relations in concert with department leads.

Before founding VoxNeuro, Kimberly made her career in account management at leading creative advertising agencies including DentsuBos in Toronto and mcgarrybowen in New York. From managing clients including JCPenney in the US market, and Canon and Manulife in Canada, Kimberly developed strong skills in communications, strategy, budget and project management – keeping clients and her teams focused, on time and on budget.

Kimberly was born in Calgary and grew up primarily overseas in The Netherlands and Malaysia before returning to Canada for university and to start her career. With a world view engrained in her thinking, she’s laser focused on the global impact VoxNeuro will have on how brain health is managed.

Sam Chebib
Sam Chebib
Chief Strategist

As Chief Strategist, Sam is responsible for driving the development of VoxNeuro’s long term strategy alongside the Executive team, with a focus on growing shareholder value.

Sam Chebib was the President and Chief Executive Officer of Nightingale since he founded the company in 2002. Under his guidance the company became a cloud-based EHR leader in North America. Nightingale was number one on the Deloitte Fast 50 in Canada, number ten on the Deloitte Fast 500 in North America and ranked as the third largest Healthcare Information Technology company on the Branham 300. Nightingale was acquired by Telus Health in 2016 and Sam joined VoxNeuro shortly after.

Doug Watt
Doug Watt
Chief Revenue Officer

As Chief Revenue Officer, Doug oversees sales, marketing and customer engagement to drive VoxNeuro’s national and international expansion strategy through the growth of VoxNeuro’c clinical network.

Doug has spent the majority of his career in Consulting and Software, with the last 20 years focused on Healthcare. Before joining VoxNeuro, Doug worked at Deloitte, where as a Senior Advisor to the Digital Health team he led large programs with the Ontario Ministry of Health, Alberta Health and BC Ministry of Health.

Prior to Deloitte, Doug spent 6.5 years with eHealth Ontario. As Senior Vice President overseeing Product Management and Account Management, he drove the Agency’s Digital Health and Clinical Data solutions. Doug held a number of executive positions with Nightingale Informatix in the years prior, leading adoption of innovative technologies at healthcare organizations and physicians’ practices.

Dr. Kyle I. Ruiter
Dr. Kyle I. Ruiter
Vice President, Clinical & Scientific Affairs

As Vice President, Clinical & Scientific Affairs, Kyle is responsible for ensuring the highest standard of care for patients through the strategic leadership of VoxNeuro’s clinical and scientific practices. This includes the oversight of the Research & Development, Clinical Operations and Regulatory Affairs & Quality Assurance departments, with a focus on product development and expanding the medical applications of VoxNeuro’s technology.

Dr. Ruiter was awarded his Ph.D. from McMaster University’s Cognitive Science of Language Program. Dr. Ruiter received extensive training in cognitive neuroscience; specifically, with expertise in electrophysiology and the neurophysiological consequences of concussion and other traumatic brain injuries (TBIs). He has been published in numerous peer-reviewed journals for his research in brain injury and neuroimaging. Additionally, Dr. Ruiter is well-versed in regulatory affairs; in particular, medical device hardware and software regulation for both Health Canada (HC) and the FDA. In addition to his PhD, Dr. Ruiter holds a diploma in General Arts and Science from Humber College, a Honours Bachelor’s of Applied Science in Psychology with an emphasis in Business Administration from the University of Guelph, as well as a post-graduate certificate in Regulatory Affairs from Algonquin College.

Christopher Seminerio
Christopher Seminerio
Director of Sales & Strategic Partnerships

As Director of Sales & Strategic Partnerships, Christopher leads the business development team growing VoxNeuro’s services in private clinics, hospital networks & pharmaceutical companies. He also builds research initiatives focused in hospital & university networks.

Christopher has 10+ years experience as a professional corporate sales representative in consumer packaged goods with Frito Lay Canada, technology and services with Xerox Canada and in supply chain and logistics with Purolator. He graduated from the University of Ottawa with a Bachelor of Commerce in Marketing.

After spending the majority of the first 23 years of his life in Canada Christopher promptly moved to South Korea upon graduation. He left behind the prospects of a great job to experience a new challenge by being introduced to a new culture while making connections that expand the globe today. What motivates Christopher most is taking groundbreaking technology that is backed by world class research from a renowned science team is an exciting opportunity to be a part of. VoxNeuro is pushing the understanding of the brain and providing a technology that will help millions of people suffering from cognitive issues. Also being a part of a young, driven, mission focused team that wants to help people.

Dewey Mai
Dewey Mai
Technical Director of Product Development, AI & Technology

Dewey Mai is the Technical Director of Product Development. Dewey is responsible for managing VoxNeuro’s technology product development, implementation and management. Dewey is dedicated to identifying potential improvements and new products, manages software development teams & supports VoxNeuro’s information technology.

Dewey Mai is an IT executive, entrepreneur and investor. Dewey is a technology industry veteran who previously held positions at both global publicly traded companies and agile tech startups. Dewey is a Bregman Scholar, graduating with an MBA and from the Rotman School of Management at the University of Toronto, and a Honours Bachelor of Medical Sciences in Biochemistry from the University of Western Ontario. In his spare time you can find Dewey pursuing his passion for real estate, investing and volunteering. He is particularly passionate about the role that the performing arts and education play in strong Canadian communities and is a Member of the Board at Canada’s Ballet Jörgen and a program advisory member at Humber College.

Andrew Matiasso
Andrew Matiasso, CHT™
Manager, Clinical Operations

Andrew is responsible for ensuring high standards of care for patients through the strategic leadership of clinical personnel, compliance with regulatory bodies, and the optimization of operational practices in clinical and research contexts.

Prior to VoxNeuro, Andrew worked as a Registered Kinesiologist, prescribing exercise in clinical and general populations. He completed a BSc in Kinesiology at the University of Guelph-Humber.

Danielle Gnidec
Danielle Gnidec, OTA/PTA, CHT™
Manager of Clinical Education

Danielle manages VoxNeuro’s clinical and professional practice education, including oversight and provision of quality and client centred care with VoxNeuro’s partners. As Manager of Clinical Education, Danielle proactively assesses and determines education programming for VoxNeuro’s clinical partners, is responsible for performance evaluation of clinical staff, develops learning plans, and delivers and evaluates practice education in support of the goals and objectives of VoxNeuro.

Before working at VoxNeuro, Danielle was an OTA/PTA with a number of rehabilitation clinics around the GTA. Danielle received her OTA/PTA certificate from Humber College.

Nathalee Ewers
Nathalee Ewers, MSc, CHT™
Diversity, Equity & Inclusion Lead, Corporate Social Responsibility

Nathalee is VoxNeuro’s Diversity, Equity and Inclusion Lead. Nathalee spearheaded the development of VoxNeuro’s Corporate Social Responsibility strategy: Supporting Marginalized Communities. In this role, Nathalee assists with internal and external corporate communications, informs and monitors normative data collection initiatives, provides inclusivity oversight for VoxNeuro’s technology, consults with HR on best hiring practices, and manages community engagement projects.

Nathalee recently completed her master’s in Psychology, Neuroscience and Behaviour at McMaster University, during which time she used electrophysiology to better understand how subconcussive impacts and concussions alike affect brain function. Nathalee is currently a first year medical student at Dalhousie University in Halifax. Nathalee aspires to someday work in the medical field as a neurologist, and partner with VoxNeuro to ensure that we participate in evidence-based practices.

She is passionate about VoxNeuro improving recovery from neurological trauma, and applying how her research can improve the quality of life of others. With her research experience in concussion, Nathalee is inspired by VoxNeuro offering hope for individuals dealing with symptoms that were previously “invisible”.

Adam Masciangelo
Adam Masciangelo, MSc
Regulatory Affairs & Quality Assurance Manager

Adam builds out the infrastructure required for VoxNeuro to gain market authorization globally. Adam is responsible for managing VoxNeuro’s Quality Management System, regulatory submissions to governing health authorities and continued compliance to applicable regulations.

Adam completed his Master’s of Science in Clinical Research Regulatory Affairs at Northeastern University. While working towards the completion of his Master’s degree, Adam also worked as a research assistant at Southlake Regional Health Centre in Newmarket, Ontario on projects within the Mental Health and Cancer programs.

What excites Adam most about VoxNeuro is the opportunity to help others that are struggling with cognitive deficits by leveraging our technology. Growing up an athlete, he is also motivated by the prospective impact and role VoxNeuro can play in helping athletes.

Kung Chu
Kung Chu
Digital Marketing Lead, Communications

As Digital Marketing Lead, Kung works directly with the COO to develop and manage VoxNeuro’s digital marketing strategy. Kung executes VoxNeuro’s digital marketing campaigns across a variety of channels from Paid Search, Social Media, and Display advertising. Kung has over 7 years of agency and client side across healthcare, automotive, consumer electronics, and financial services.

Industry Partners & Support

McMaster University

VoxNeuro’s science is backed by 30+ years of globally funded, peer-reviewed research led by Dr. John F. Connolly. This research began at Dalhousie University, furthered at University of Montreal, and continues to break new ground at McMaster University, where VoxNeuro launched its operations in 2017. Dr. John F. Connolly, the Chief Science Officer and co-founder of VoxNeuro, holds the Senator William McMaster Chair in Cognitive Neuroscience, is the founding director of the ARiEAL Research Centre, and co-directs the Language, Memory and Brain Lab at McMaster University. VoxNeuro works with partners at the McMaster Industry Liaison Office in the commercialization of this groundbreaking technology in brain health management, and is a graduate of The Forge, McMaster’s start-up incubator.


National Research Council Canada

VoxNeuro has received innovation support funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). Obtaining NRC IRAP funding not only serves as recognition for VoxNeuro’s focus on innovation, but will serve as a catalyst for the company’s continued growth and success.


Compumedics Neuroscan

VoxNeuro’s Cognitive Health Assessments™ use Health Canada and FDA approved electroencephalography (EEG) equipment supplied by Compumedics Neuroscan. Compumedics Neuroscan is the world’s lead­ing provider of tech­nolo­gies for high-density EEG record­ings, electro-magnetic source local­iza­tion, multi-modal neuroimag­ing and enhance­ments to func­tional MRI. Neuroscan’s prod­ucts are in use at over 1500 univer­si­ties, corpo­rate labo­ra­to­ries and national research insti­tutes in approx­i­mately 40 countries.


VoxNeuro is a member of the Hamilton Chamber of Commerce. As a part of the Hamilton community, VoxNeuro is dedicated to building Hamilton’s reputation as one of Canada’s leading innovative cities in healthcare, while helping to promote and enhance business growth and activities across the City of Hamilton.


VoxNeuro is a Platinum Corporate Sponsor of Brain Injury Canada. We share the central mission to enhance the lives of individuals, their families & caregivers living with brain injury. Brain Injury Canada, the only national charitable brain injury organization, enables access to ABI information and services for all Canadians. In 2020, Brain Injury Canada will launch an integrated and comprehensive Brain Injury Resource Website. It will serve to provide reliable & evidence-based information related to brain injury, and a comprehensive list of existing services for Canadians with brain injuries, their families and caregivers.


VoxNeuro and the Canadian Football League Alumni Association have a collaboration agreement to offer Cognitive Health Assessments to its members. Through the partnership, these groups will also raise awareness of long term impacts of head trauma, like concussion. For ageing Canadians who have experienced head-trauma throughout their lives, a growing concern is understanding its relationship with cognitive decline.


The Government of Canada’s Trade Commissioner Service selected VoxNeuro as 1 of 11 emerging growth Canadian Life Sciences companies to participate in the Canadian Technology Accelerators’ inaugural bi-coastal program led by the Consulates General of Canada in New York and San Francisco. The program, which concluded in November 2020, was dedicated to the development of high-potential, early-stage digital health start-ups into the San Francisco and New York healthcare ecosystems, priming VoxNeuro’s US market entry in 2021.

Creating Change with VoxNeuro

VoxNeuro’s mission at its core is about creating change. VoxNeuro is dedicated to improving the world’s understanding of the brain through objective measurement of core brain functions. A benefit of VoxNeuro’s Cognitive Health Assessment™ is that it facilitates access to care. VoxNeuro’s breakthrough solution in brain health management arms healthcare teams with objective data to back their medical decisions and advocate for their patient’s treatment.

In removing reliance on subjective assessments traditionally used to assess the brain, VoxNeuro’s technology gives an objective voice to otherwise invisible brain ailments. In the same manner, objective and representative data across all healthcare has the power to give a voice to patient populations who have been disproportionately affected by gaps in the healthcare system.

VoxNeuro is made up of a team who were all brought on because of their unique backgrounds. We celebrate each other’s unique lived experiences and differences, and know that this is what gives the team strength. We are the team that we are because of each other’s voices, compassion and support. This is core to our culture. Together, we are dedicated to being change agents for marginalized communities, and hope we inspire others to do what is within their power to act and to create permanent, positive, inclusive solutions.

Amplifying voices of diversity

While we strive for diversity, equity and inclusion internally, we’re taking advantage of the fact that there are a lot of eyes on our growing company. We have launched a content series dedicated to recognizing researchers and healthcare practitioners of colour in the field of neuroscience and healthcare. The goal of the series is to help educate on the challenges and gaps in brain-centred healthcare for marginalized communities.

VoxNeuro is actively seeking individuals to get involved in this initiative. If you are interested in being interviewed, or have someone you’d like to nominate, please contact us at [email protected]

Read VoxNeuro’s statement on anit-black racism that inspired this content series.

Sign-up for VoxNeuro’s Newsletter

expand_less